世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の吸入抗感染症薬市場レポート、歴史と予測2018-2029年、メーカー別内訳データ、主要地域別、タイプ別、用途別


Global Inhaled Anti-Infectives Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

QYResearch社の調査レポート「吸入抗感染症薬」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の吸入抗感染症薬市場は、2022年の3億8,200万米ドルから202... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年10月23日 US$3,350
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

QYResearch社の調査レポート「吸入抗感染症薬」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の吸入抗感染症薬市場は、2022年の3億8,200万米ドルから2029年には6億3,650万米ドルに達すると予測され、2023年から2029年までの年平均成長率は5.6%である。病院薬局と小売薬局からの需要が業界の主な促進要因である。

世界の医薬品市場は2022年に1,475億ドルに達し、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19パンデミックはワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。

レポートの範囲
本レポートは、過去の分析(2018-2022年)と予測計算(2023-2029年)に基づき、読者が世界の吸入抗感染症薬市場を多角的に包括的に理解し、読者の戦略と意思決定に十分な支援を提供することを目的としています。

レポートに掲載されているメーカー、タイプ、用途、地域
企業別
アストラゼネカ
ジョンソン・エンド・ジョンソン
グラクソ・スミスクライン
ノバルティスAG
ファイザー
ウォックハルト
ロシュ
サノフィ
メルク
タイプ別セグメント
エアゾール
ドライパウダー製剤
スプレー
用途別セグメント
病院薬局
小売薬局
オンライン薬局
地域別セグメント
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦

本レポートの各章は、読者が吸入抗感染症薬市場をさらに理解するための詳細な情報を提供します:
第1章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品定義、製品タイプ、各タイプの販売量および収益分析。
第2章:売上高と収益の比較を含むメーカーの競争状況、吸入抗感染薬のメーカーの商業日、各メーカーが提供する製品タイプ、M&A活動、吸入抗感染薬業界で発生した拡張活動。
第3章:北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカにおける吸入抗感染症の過去(2018-2022年)および予測(2023-2029年)の数量と収益分析。
第4章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途、各用途の数量および収益分析。
第5章から第9章:北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカの国別レベル分析、数量および収益分析を含む。
第10章:メーカーの概要、本社、連絡先、主要事業、吸入抗感染症薬の紹介などの企業の基本情報をカバーする。また、各社の売上高、収益、価格、グロスマージン、最近の動向もこの部分に含まれています。
第11章:原材料、製造コストのような産業チェーンがカバーされています。加えて、市場機会と課題もこの章で強調されている。
第12章:市場チャネル、流通業者と顧客がリストアップされています。
第13章包括的な調査に基づくQYResearchの吸入抗感染症薬市場の結論。
第14章:QYResearchが採用した方法論とデータソース。


ページTOPに戻る


目次

1 Inhaled Anti-Infectives Market Overview
1.1 Inhaled Anti-Infectives Product Overview
1.2 Inhaled Anti-Infectives Market Segment by Type
1.2.1 Aerosol
1.2.2 Dry Powder Formulation
1.2.3 Spray
1.3 Global Inhaled Anti-Infectives Market Size by Type
1.3.1 Global Inhaled Anti-Infectives Market Size Overview by Type (2018-2029)
1.3.2 Global Inhaled Anti-Infectives Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
2 Global Inhaled Anti-Infectives Market Competition by Company
2.1 Global Top Players by Inhaled Anti-Infectives Sales (2018-2023)
2.2 Global Top Players by Inhaled Anti-Infectives Revenue (2018-2023)
2.3 Global Top Players by Inhaled Anti-Infectives Price (2018-2023)
2.4 Global Top Manufacturers Inhaled Anti-Infectives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inhaled Anti-Infectives Market Competitive Situation and Trends
2.5.1 Inhaled Anti-Infectives Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inhaled Anti-Infectives Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inhaled Anti-Infectives as of 2022)
2.7 Date of Key Manufacturers Enter into Inhaled Anti-Infectives Market
2.8 Key Manufacturers Inhaled Anti-Infectives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inhaled Anti-Infectives Status and Outlook by Region
3.1 Global Inhaled Anti-Infectives Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inhaled Anti-Infectives Historic Market Size by Region
3.2.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2018-2023)
3.2.2 Global Inhaled Anti-Infectives Sales in Value by Region (2018-2023)
3.2.3 Global Inhaled Anti-Infectives Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Region
3.3.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2024-2029)
3.3.2 Global Inhaled Anti-Infectives Sales in Value by Region (2024-2029)
3.3.3 Global Inhaled Anti-Infectives Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inhaled Anti-Infectives by Application
4.1 Inhaled Anti-Infectives Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Inhaled Anti-Infectives Market Size by Application
4.2.1 Global Inhaled Anti-Infectives Market Size Overview by Application (2018-2029)
4.2.2 Global Inhaled Anti-Infectives Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inhaled Anti-Infectives Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
5 North America Inhaled Anti-Infectives by Country
5.1 North America Inhaled Anti-Infectives Historic Market Size by Country
5.1.1 North America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
5.1.3 North America Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
5.2 North America Inhaled Anti-Infectives Forecasted Market Size by Country
5.2.1 North America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
5.2.2 North America Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
6 Europe Inhaled Anti-Infectives by Country
6.1 Europe Inhaled Anti-Infectives Historic Market Size by Country
6.1.1 Europe Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
6.1.3 Europe Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
6.2 Europe Inhaled Anti-Infectives Forecasted Market Size by Country
6.2.1 Europe Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
6.2.2 Europe Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
7 Asia-Pacific Inhaled Anti-Infectives by Region
7.1 Asia-Pacific Inhaled Anti-Infectives Historic Market Size by Region
7.1.1 Asia-Pacific Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inhaled Anti-Infectives Forecasted Market Size by Region
7.2.1 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2024-2029)
8 Latin America Inhaled Anti-Infectives by Country
8.1 Latin America Inhaled Anti-Infectives Historic Market Size by Country
8.1.1 Latin America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
8.2 Latin America Inhaled Anti-Infectives Forecasted Market Size by Country
8.2.1 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
9 Middle East and Africa Inhaled Anti-Infectives by Country
9.1 Middle East and Africa Inhaled Anti-Infectives Historic Market Size by Country
9.1.1 Middle East and Africa Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inhaled Anti-Infectives Forecasted Market Size by Country
9.2.1 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Astra Zeneca
10.1.1 Astra Zeneca Company Information
10.1.2 Astra Zeneca Introduction and Business Overview
10.1.3 Astra Zeneca Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Astra Zeneca Inhaled Anti-Infectives Products Offered
10.1.5 Astra Zeneca Recent Development
10.2 Johnson &Johnson
10.2.1 Johnson &Johnson Company Information
10.2.2 Johnson &Johnson Introduction and Business Overview
10.2.3 Johnson &Johnson Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson &Johnson Inhaled Anti-Infectives Products Offered
10.2.5 Johnson &Johnson Recent Development
10.3 Glaxo SmithKline
10.3.1 Glaxo SmithKline Company Information
10.3.2 Glaxo SmithKline Introduction and Business Overview
10.3.3 Glaxo SmithKline Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Glaxo SmithKline Inhaled Anti-Infectives Products Offered
10.3.5 Glaxo SmithKline Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Company Information
10.4.2 Novartis AG Introduction and Business Overview
10.4.3 Novartis AG Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis AG Inhaled Anti-Infectives Products Offered
10.4.5 Novartis AG Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Inhaled Anti-Infectives Products Offered
10.5.5 Pfizer Recent Development
10.6 Wockhardt
10.6.1 Wockhardt Company Information
10.6.2 Wockhardt Introduction and Business Overview
10.6.3 Wockhardt Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Wockhardt Inhaled Anti-Infectives Products Offered
10.6.5 Wockhardt Recent Development
10.7 Roche
10.7.1 Roche Company Information
10.7.2 Roche Introduction and Business Overview
10.7.3 Roche Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Roche Inhaled Anti-Infectives Products Offered
10.7.5 Roche Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Inhaled Anti-Infectives Products Offered
10.8.5 Sanofi Recent Development
10.9 Merck
10.9.1 Merck Company Information
10.9.2 Merck Introduction and Business Overview
10.9.3 Merck Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Merck Inhaled Anti-Infectives Products Offered
10.9.5 Merck Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inhaled Anti-Infectives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inhaled Anti-Infectives Industrial Chain Analysis
11.4 Inhaled Anti-Infectives Market Dynamics
11.4.1 Inhaled Anti-Infectives Industry Trends
11.4.2 Inhaled Anti-Infectives Market Drivers
11.4.3 Inhaled Anti-Infectives Market Challenges
11.4.4 Inhaled Anti-Infectives Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inhaled Anti-Infectives Distributors
12.3 Inhaled Anti-Infectives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る


 

Summary

Inhaled Anti-Infectives report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Inhaled Anti-Infectives market is projected to reach US$ 636.5 million in 2029, increasing from US$ 382 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inhaled Anti-Infectives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Astra Zeneca
Johnson &Johnson
Glaxo SmithKline
Novartis AG
Pfizer
Wockhardt
Roche
Sanofi
Merck
Segment by Type
Aerosol
Dry Powder Formulation
Spray
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Each chapter of the report provides detailed information for readers to understand the Inhaled Anti-Infectives market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inhaled Anti-Infectives, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inhaled Anti-Infectives industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Inhaled Anti-Infectives in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inhaled Anti-Infectives introduction, etc. Inhaled Anti-Infectives Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Inhaled Anti-Infectives market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.



ページTOPに戻る


Table of Contents

1 Inhaled Anti-Infectives Market Overview
1.1 Inhaled Anti-Infectives Product Overview
1.2 Inhaled Anti-Infectives Market Segment by Type
1.2.1 Aerosol
1.2.2 Dry Powder Formulation
1.2.3 Spray
1.3 Global Inhaled Anti-Infectives Market Size by Type
1.3.1 Global Inhaled Anti-Infectives Market Size Overview by Type (2018-2029)
1.3.2 Global Inhaled Anti-Infectives Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023)
2 Global Inhaled Anti-Infectives Market Competition by Company
2.1 Global Top Players by Inhaled Anti-Infectives Sales (2018-2023)
2.2 Global Top Players by Inhaled Anti-Infectives Revenue (2018-2023)
2.3 Global Top Players by Inhaled Anti-Infectives Price (2018-2023)
2.4 Global Top Manufacturers Inhaled Anti-Infectives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inhaled Anti-Infectives Market Competitive Situation and Trends
2.5.1 Inhaled Anti-Infectives Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inhaled Anti-Infectives Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inhaled Anti-Infectives as of 2022)
2.7 Date of Key Manufacturers Enter into Inhaled Anti-Infectives Market
2.8 Key Manufacturers Inhaled Anti-Infectives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inhaled Anti-Infectives Status and Outlook by Region
3.1 Global Inhaled Anti-Infectives Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inhaled Anti-Infectives Historic Market Size by Region
3.2.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2018-2023)
3.2.2 Global Inhaled Anti-Infectives Sales in Value by Region (2018-2023)
3.2.3 Global Inhaled Anti-Infectives Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Region
3.3.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2024-2029)
3.3.2 Global Inhaled Anti-Infectives Sales in Value by Region (2024-2029)
3.3.3 Global Inhaled Anti-Infectives Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inhaled Anti-Infectives by Application
4.1 Inhaled Anti-Infectives Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Inhaled Anti-Infectives Market Size by Application
4.2.1 Global Inhaled Anti-Infectives Market Size Overview by Application (2018-2029)
4.2.2 Global Inhaled Anti-Infectives Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inhaled Anti-Infectives Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023)
5 North America Inhaled Anti-Infectives by Country
5.1 North America Inhaled Anti-Infectives Historic Market Size by Country
5.1.1 North America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
5.1.3 North America Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
5.2 North America Inhaled Anti-Infectives Forecasted Market Size by Country
5.2.1 North America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
5.2.2 North America Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
6 Europe Inhaled Anti-Infectives by Country
6.1 Europe Inhaled Anti-Infectives Historic Market Size by Country
6.1.1 Europe Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
6.1.3 Europe Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
6.2 Europe Inhaled Anti-Infectives Forecasted Market Size by Country
6.2.1 Europe Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
6.2.2 Europe Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
7 Asia-Pacific Inhaled Anti-Infectives by Region
7.1 Asia-Pacific Inhaled Anti-Infectives Historic Market Size by Region
7.1.1 Asia-Pacific Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inhaled Anti-Infectives Forecasted Market Size by Region
7.2.1 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2024-2029)
8 Latin America Inhaled Anti-Infectives by Country
8.1 Latin America Inhaled Anti-Infectives Historic Market Size by Country
8.1.1 Latin America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
8.2 Latin America Inhaled Anti-Infectives Forecasted Market Size by Country
8.2.1 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
9 Middle East and Africa Inhaled Anti-Infectives by Country
9.1 Middle East and Africa Inhaled Anti-Infectives Historic Market Size by Country
9.1.1 Middle East and Africa Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inhaled Anti-Infectives Forecasted Market Size by Country
9.2.1 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Astra Zeneca
10.1.1 Astra Zeneca Company Information
10.1.2 Astra Zeneca Introduction and Business Overview
10.1.3 Astra Zeneca Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Astra Zeneca Inhaled Anti-Infectives Products Offered
10.1.5 Astra Zeneca Recent Development
10.2 Johnson &Johnson
10.2.1 Johnson &Johnson Company Information
10.2.2 Johnson &Johnson Introduction and Business Overview
10.2.3 Johnson &Johnson Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson &Johnson Inhaled Anti-Infectives Products Offered
10.2.5 Johnson &Johnson Recent Development
10.3 Glaxo SmithKline
10.3.1 Glaxo SmithKline Company Information
10.3.2 Glaxo SmithKline Introduction and Business Overview
10.3.3 Glaxo SmithKline Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Glaxo SmithKline Inhaled Anti-Infectives Products Offered
10.3.5 Glaxo SmithKline Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Company Information
10.4.2 Novartis AG Introduction and Business Overview
10.4.3 Novartis AG Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis AG Inhaled Anti-Infectives Products Offered
10.4.5 Novartis AG Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Inhaled Anti-Infectives Products Offered
10.5.5 Pfizer Recent Development
10.6 Wockhardt
10.6.1 Wockhardt Company Information
10.6.2 Wockhardt Introduction and Business Overview
10.6.3 Wockhardt Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Wockhardt Inhaled Anti-Infectives Products Offered
10.6.5 Wockhardt Recent Development
10.7 Roche
10.7.1 Roche Company Information
10.7.2 Roche Introduction and Business Overview
10.7.3 Roche Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Roche Inhaled Anti-Infectives Products Offered
10.7.5 Roche Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Inhaled Anti-Infectives Products Offered
10.8.5 Sanofi Recent Development
10.9 Merck
10.9.1 Merck Company Information
10.9.2 Merck Introduction and Business Overview
10.9.3 Merck Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Merck Inhaled Anti-Infectives Products Offered
10.9.5 Merck Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inhaled Anti-Infectives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inhaled Anti-Infectives Industrial Chain Analysis
11.4 Inhaled Anti-Infectives Market Dynamics
11.4.1 Inhaled Anti-Infectives Industry Trends
11.4.2 Inhaled Anti-Infectives Market Drivers
11.4.3 Inhaled Anti-Infectives Market Challenges
11.4.4 Inhaled Anti-Infectives Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inhaled Anti-Infectives Distributors
12.3 Inhaled Anti-Infectives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04 10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る